# Transcriptomic Analysis Reveals the Molecular Mechanisms of Prolactin in Regulating Porcine Follicular Development

**Authors:** Yubin You, Beibei Han, Qiang He, Li Li, Shouquan Zhang, Hengxi Wei

PMC · DOI: 10.3390/genes16070774 · 2025-06-30

## TL;DR

This study explores how prolactin influences pig follicular development by analyzing gene expression and signaling pathways.

## Contribution

The study identifies specific molecular mechanisms and signaling pathways through which prolactin regulates porcine follicular development.

## Key findings

- Prolactin levels and related gene expressions increase in larger porcine follicles.
- Prolactin promotes granulosa cell proliferation and enhances angiogenic factors like VEGFA and FGF-2.
- RNA-seq revealed 226 differentially expressed genes enriched in Hippo, JAK/STAT, and Rap1 pathways.

## Abstract

Background: Prolactin (PRL) is a key reproductive hormone that regulates follicular development through endocrine and paracrine mechanisms. However, its specific role in porcine follicular development remains unclear. Methods: In the in vivo experiments, follicular fluid and tissue cells were obtained from small (1–2 mm), medium (3–4 mm), and large (5–6 mm) porcine follicles. PRL levels in follicular fluid were measured by ELISA. The expression levels of genes and proteins related to follicular development were assessed using quantitative real-time PCR (RT-qPCR) and Western blotting (WB). In the in vitro experiments, CCK-8, RT-qPCR, and WB were used to detect the effects of different concentrations (0, 30, and 300 ng/mL) of recombinant porcine prolactin (prPRL) on granulosa cell (GC) proliferation, steroid hormone synthesis, and angiogenesis, and transcriptome sequencing was performed. Results: The PRL concentration was significantly higher in large follicles compared to small and medium follicles. During follicular development, expression levels of PRL, PRL receptor (PRLR), proteolytic enzymes (CTSD, MMP2, MMP14, and BMP-1), and angiogenic factors (VEGFA and FGF-2) increased and then decreased. Moreover, prPRL promoted GC proliferation, increased the expression of PCNA and cyclin D1, upregulated steroidogenesis-related genes CYP11A1 and 3β-HSD, and significantly enhanced the expression of key angiogenic factors VEGFA and FGF-2. RNA-seq analysis identified 226 differentially expressed genes (DEGs), which were mainly enriched in signaling pathways such as the Hippo, JAK/STAT, and Rap1 pathways. Conclusions: PRL may regulate porcine follicle development by affecting cell proliferation and angiogenesis in GCs through the Hippo, JAK/STAT and Rap1 signaling pathways.

## Linked entities

- **Genes:** PRL (prolactin) [NCBI Gene 5617], PRLR (prolactin receptor) [NCBI Gene 5618], CTSD (cathepsin D) [NCBI Gene 1509], MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313], MMP14 (matrix metallopeptidase 14) [NCBI Gene 4323], BMP1 (bone morphogenetic protein 1) [NCBI Gene 649], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], FGF2 (fibroblast growth factor 2) [NCBI Gene 2247], PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111], ccnd1.S (cyclin D1 S homeolog) [NCBI Gene 379161], CYP11A1 (cytochrome P450 family 11 subfamily A member 1) [NCBI Gene 1583], 3BHSD (3beta-hydroxysteroid dehydrogenase/isomerase) [NCBI Gene 100860869]

## Full-text entities

- **Genes:** BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, HSD3B1 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1) [NCBI Gene 3283] {aka 3BETAHSD, HSD3B, HSDB3, HSDB3A, SDR11E1}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, PRL (prolactin) [NCBI Gene 5617] {aka GHA1, pPRL}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, PRLR (prolactin receptor) [NCBI Gene 5618] {aka HPRL, MFAB, RI-PRLR, hPRLrI}, CYP11A1 (cytochrome P450 family 11 subfamily A member 1) [NCBI Gene 1583] {aka CYP11A, CYPXIA1, P450SCC}, CTSD (cathepsin D) [NCBI Gene 1509] {aka CLN10, CPSD, HEL-S-130P}, MMP14 (matrix metallopeptidase 14) [NCBI Gene 4323] {aka MMP-14, MMP-X1, MT-MMP, MT-MMP 1, MT1-MMP, MT1MMP}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, RAP1A (RAP1A, member of RAS oncogene family) [NCBI Gene 5906] {aka C21KG, G-22K, KREV-1, KREV1, RAP1, SMGP21}
- **Chemicals:** steroid hormone (MESH:D013256), CCK-8 (MESH:D012844)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12296069/full.md

---
Source: https://tomesphere.com/paper/PMC12296069